Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by harnessing the body's immune system to target ...

Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...

One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

Such an advancement would allow for one of the most successful non-chemo cancer treatments to be done both faster and cheaper ...

Two recent studies show the novel therapy works in people with multiple myeloma, but researchers are trying to minimize side ...

Saved from precursor B-cell acute lymphoblastic leukemia, the Nobel Prize winning CAR T-cell therapy gave Bryn Ailinger a ...

Chimeric antigen receptor (CAR) T-cell therapy is an innovative cancer treatment that engineers a patient’s own T cells to target and destroy cancer cells. While the field has sparked significant ...

Siteman Cancer Center is among the first cancer centers in the nation to pioneer a treatment described as “a last line of defense for many patients,” according to the center’s deputy director, Dr.

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

Northwestern scientists said they found pancreatic cancer cells play a trick on a person's immune system by wearing a sugar ...